[go: up one dir, main page]

DK256977A - Fremgangsmaade til fremstilling af flerdobbelt halogenerede steroider - Google Patents

Fremgangsmaade til fremstilling af flerdobbelt halogenerede steroider

Info

Publication number
DK256977A
DK256977A DK256977A DK256977A DK256977A DK 256977 A DK256977 A DK 256977A DK 256977 A DK256977 A DK 256977A DK 256977 A DK256977 A DK 256977A DK 256977 A DK256977 A DK 256977A
Authority
DK
Denmark
Prior art keywords
procedure
production
double halogenated
halogenated steroids
steroids
Prior art date
Application number
DK256977A
Other languages
English (en)
Other versions
DK146017C (da
DK146017B (da
Inventor
J Kalvoda
G Anner
Original Assignee
Ciba Geigy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy filed Critical Ciba Geigy
Publication of DK256977A publication Critical patent/DK256977A/da
Publication of DK146017B publication Critical patent/DK146017B/da
Application granted granted Critical
Publication of DK146017C publication Critical patent/DK146017C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • C07J7/0085Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by an halogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J21/00Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J31/00Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0069Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C07J5/0076Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005Oxygen-containing hetero ring
    • C07J71/001Oxiranes
    • C07J71/0015Oxiranes at position 9(11)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK256977A 1976-09-29 1977-06-09 Analogifremgangsmaade til fremstilling af 17alfa-acyloxy-9alfa,21-dihalogen-11beta-hydroxy-6alfa-fluor-16beta-methyl-pregna-1,4-dien-3,20-dion-forbindelser DK146017C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
LU75903 1976-09-29
LU75903A LU75903A1 (da) 1976-09-29 1976-09-29

Publications (3)

Publication Number Publication Date
DK256977A true DK256977A (da) 1978-03-30
DK146017B DK146017B (da) 1983-05-24
DK146017C DK146017C (da) 1983-10-24

Family

ID=19728370

Family Applications (1)

Application Number Title Priority Date Filing Date
DK256977A DK146017C (da) 1976-09-29 1977-06-09 Analogifremgangsmaade til fremstilling af 17alfa-acyloxy-9alfa,21-dihalogen-11beta-hydroxy-6alfa-fluor-16beta-methyl-pregna-1,4-dien-3,20-dion-forbindelser

Country Status (24)

Country Link
JP (1) JPS5356652A (da)
AT (3) AT363197B (da)
AU (1) AU514200B2 (da)
BE (1) BE859120A (da)
CA (1) CA1101410A (da)
CH (9) CH624967A5 (da)
CY (1) CY1178A (da)
DD (1) DD133150A5 (da)
DE (1) DE2743069C2 (da)
DK (1) DK146017C (da)
ES (1) ES462763A1 (da)
FR (1) FR2366311A1 (da)
GB (1) GB1563638A (da)
HK (1) HK16683A (da)
HU (1) HU175218B (da)
IE (1) IE46047B1 (da)
IL (1) IL53012A (da)
KE (1) KE3258A (da)
LU (1) LU75903A1 (da)
MY (1) MY8400092A (da)
NL (1) NL7710089A (da)
SE (1) SE436751B (da)
SG (1) SG3383G (da)
ZA (1) ZA775800B (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL187577C (nl) * 1978-04-05 1991-11-18 Sibla Srl 3-acetoxy-9beta,11beta-epoxy-pregna-1,3,5-trienen, werkwijze voor de bereiding daarvan en werkwijze voor de bereiding van 6alfa-halogeen-pregna-1,4-dieen-3-onen.
DE3227312A1 (de) * 1982-07-19 1984-01-19 Schering AG, 1000 Berlin und 4709 Bergkamen Neue 6,16-dimethylkortikoide, ihre herstellung und verwendung
JPH05501115A (ja) * 1990-03-27 1993-03-04 シェリング・コーポレーション 9α―ヒドロキシ ステロイドの脱水法
US5972922A (en) * 1990-06-11 1999-10-26 Alcon Laboratories, Inc. Steroids which inhibit angiogenesis
EP1465855A2 (en) 2001-11-29 2004-10-13 Taro Pharmaceuticals U.S.A., Inc. Method for the production of 6-alpha-fluoro corticosteroids
US11957753B2 (en) 2010-11-22 2024-04-16 Bausch Health Ireland Limited Pharmaceutical formulations containing corticosteroids for topical administration
US8809307B2 (en) 2010-11-22 2014-08-19 Dow Pharmaceutical Sciences, Inc. Pharmaceutical formulations containing corticosteroids for topical administration
US10251895B2 (en) 2015-06-18 2019-04-09 Valeant Pharmaceuticals North America Topical compositions and methods for treating psoriasis
US11311482B2 (en) 2017-05-12 2022-04-26 Bausch Health Us, Llc Topical compositions and methods for treating skin diseases

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB898292A (en) * 1959-03-18 1962-06-06 Upjohn Co Improvements in or relating to steroids and the manufacture thereof
US3644340A (en) * 1970-03-19 1972-02-22 Syntex Corp Preparation of 21-chloro steroids
US3992422A (en) * 1975-08-14 1976-11-16 Schering Corporation Process for the preparation of 21-halogeno-21-desoxy-17α-acyloxy-20-keto-pregnenes

Also Published As

Publication number Publication date
FR2366311B1 (da) 1982-12-03
JPS6214557B2 (da) 1987-04-02
AT363203B (de) 1981-07-27
CH624967A5 (en) 1981-08-31
CA1101410A (en) 1981-05-19
DE2743069A1 (de) 1978-03-30
HK16683A (en) 1983-05-27
ES462763A1 (es) 1978-05-16
AU514200B2 (en) 1981-01-29
CH625808A5 (en) 1981-10-15
CH625809A5 (en) 1981-10-15
GB1563638A (en) 1980-03-26
IE46047B1 (en) 1983-02-09
DD133150A5 (de) 1978-12-13
LU75903A1 (da) 1978-05-16
ATA151279A (de) 1980-12-15
ZA775800B (en) 1978-08-30
SE7706673L (sv) 1978-03-30
BE859120A (fr) 1978-03-28
DK146017C (da) 1983-10-24
DK146017B (da) 1983-05-24
KE3258A (en) 1983-03-04
SE436751B (sv) 1985-01-21
CH632000A5 (en) 1982-09-15
ATA151379A (de) 1980-12-15
IL53012A (en) 1982-05-31
CH631998A5 (en) 1982-09-15
FR2366311A1 (fr) 1978-04-28
CH632279A5 (en) 1982-09-30
CH632521A5 (en) 1982-10-15
DE2743069C2 (de) 1987-03-05
HU175218B (hu) 1980-06-28
JPS5356652A (en) 1978-05-23
CY1178A (en) 1983-06-10
CH625810A5 (en) 1981-10-15
AU2914877A (en) 1979-04-05
IE46047L (en) 1978-03-29
CH631999A5 (en) 1982-09-15
NL7710089A (nl) 1978-03-31
AT363197B (de) 1981-07-10
ATA691077A (de) 1980-12-15
SG3383G (en) 1983-09-09
AT363202B (de) 1981-07-27
MY8400092A (en) 1984-12-31
IL53012A0 (en) 1977-11-30

Similar Documents

Publication Publication Date Title
DK492677A (da) Fremgangsmaade til fremstilling af substituerede benzam9der
DK399577A (da) Fremgangsmaade til fremstilling af urinstof
DK377A (da) Fremgangsmade til fremstilling af n-phosphonomethyl-glycin
DK207178A (da) Fremgangsmaade til fremstilling af sojaskraa
DK244577A (da) Fremgangsmade til fremstilling af hydantoinderivater
DK339677A (da) Fremgangsmade til fremstilling af 2-benzylpyrrolidiner
DK256977A (da) Fremgangsmaade til fremstilling af flerdobbelt halogenerede steroider
DK452578A (da) Fremgangsmaade til fremstilling af furanderivater
DK31377A (da) Fremgangsmade til fremstilling af et antihypertensivt middel
DK144377A (da) Fremgangsmade til fremstilling af acylcyanider
DK377978A (da) Fremgangsmaade til fremstilling af opskummede plaststoffer
DK192778A (da) Fremgangsmaade til fremstilling af bisamidiner
DK97877A (da) Fremgangsmade til fremstilling af urinstofderivater
DK502077A (da) Fremgangsmaade til fremstilling af gammapyroner
DK216977A (da) Fremgangsmade til fremstilling af imidazobenzoxaziner
DK144277A (da) Fremgangsmade til fremstilling af acylcyanider
DK87977A (da) Fremgangsmade til fremstilling af benzylestere
DK73977A (da) Fremgangsmade til fremstilling af d-homosteroider
DK379277A (da) Fremgangsmaade til fremstilling af prostaglandinanaloge
DK551677A (da) Fremgangsmaade til fremstilling af prostaglandinanaloge
DK140728B (da) Fremgangsmåde til fremstilling af pregnanderivater.
DK159878A (da) Fremgangsmaade til fremstilling af urokinase
DK98478A (da) Fremgangsmaade til fremstilling af antibiotika
DK148775C (da) Fremgangsmaade til fremstilling af oelurt
DK558378A (da) Fremgangsmaade til fremstilling af alfacyanobensylestere

Legal Events

Date Code Title Description
PUP Patent expired